Blood-based Biomarkers for IL-23 Inhibitor Response in IBD

by | May 9, 2025 | Cao, Siyan, Deepak, Parakkal

— Published Date: 5/10/2025

Value Proposition: Diagnostic method that uses the patient’s PBMCs acquired before or immediately after the onset of IL-23 therapy to determine the presence of signatures indicative of long-term IL-23 response.

Technology Description

Researchers at Washington Univ…